Bharat Immunological & Biological Corporation reports standalone net loss of Rs 3.08 crore in the September 2022 quarter
Sales rise 7.21% to Rs 26.48 crore
Net Loss of Bharat Immunological & Biological Corporation reported to Rs 3.08 crore in the quarter ended September 2022 as against net loss of Rs 9.36 crore during the previous quarter ended September 2021. Sales rose 7.21% to Rs 26.48 crore in the quarter ended September 2022 as against Rs 24.70 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales26.4824.70 7 OPM %-9.44-14.13 -PBDT-3.92-4.50 13 PBT-3.96-4.56 13 NP-3.08-9.36 67Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content